Share on LinkedInShare on LinkedIn

ARTICLE · 25 APRIL 2025

The Implications Of AI-Assisted Drug Development On Patent Challenges

The emergence of artificial intelligence (AI) in drug development has significant ramifications for the pharmaceutical industry, patent law, and potential patent challengers.

United StatesTechnology

The emergence of artificial intelligence (AI) in drug development has significant ramifications for the pharmaceutical industry, patent law, and potential patent challengers. As companies increasingly rely on AI to identify promising drug candidates and streamline development processes, understanding how this technology intersects with patent law is crucial for anyone who is looking to challenge effectively the patents that will inevitably result.

Revolutionizing Drug Development

An article from The Economist last year highlighted how AI tools are transforming the landscape of drug discovery. The potential to reduce the time and costs of preclinical drug development by 25-50% marks a significant leap forward. Noteworthy examples include BenevolentAI's use of AI to identify baricitinib as a potential COVID-19 treatment. Companies like Genentech and Insilico Medicine have publicized their efforts to employ AI in the drug identification and development space.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from